Company Performance: Revenue growth, profitability, and successful drug development pipelines directly impact investor confidence and stock price. Positive clinical trial results often lead to price surges.

Market Sentiment: General market trends, industry-specific news (pharmaceutical sector), and investor risk appetite influence stock valuations. Positive sentiment in healthcare boosts GLAND.BK.

Economic Factors: Interest rates, inflation, and overall economic growth affect investment decisions and impact stock prices. Higher interest rates might decrease investment appetite.

Regulatory Environment: Changes in drug approval processes, patent laws, and healthcare regulations can significantly affect pharmaceutical companies like GLAND.BK, impacting investor outlook.

Competition: The emergence of competing drugs or therapies from other pharmaceutical companies can erode market share and decrease GLAND.BK's stock value.

Global Health Crises: Pandemics or major health events can both positively (increased demand for certain drugs) or negatively (supply chain disruptions) affect GLAND.BK's operations and stock.

Mergers & Acquisitions: Potential acquisitions or mergers involving GLAND.BK can lead to speculation and price fluctuations depending on the terms and perceived value of the deal.

Investor Confidence: News about key personnel changes, analyst ratings, or large institutional investors buying/selling shares can shift investor confidence and impact stock prices.